No abstract available
MeSH terms
-
Adult
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Coronary Disease / complications
-
Coronary Disease / diagnosis
-
Coronary Disease / drug therapy*
-
Coronary Disease / mortality
-
Electrocardiography
-
Female
-
Fibrinolytic Agents / adverse effects
-
Fibrinolytic Agents / therapeutic use*
-
Hemorrhage / chemically induced*
-
Heparin / adverse effects
-
Heparin / therapeutic use*
-
Humans
-
Linear Models
-
Logistic Models
-
Male
-
Middle Aged
-
Myocardial Infarction / etiology
-
Myocardial Infarction / mortality
-
Patient Selection
-
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
-
Prognosis
-
Risk Factors
-
Safety
-
Time Factors
-
Tirofiban
-
Treatment Outcome
-
Tyrosine / adverse effects
-
Tyrosine / analogs & derivatives
-
Tyrosine / therapeutic use*
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Platelet Glycoprotein GPIIb-IIIa Complex
-
Tyrosine
-
Heparin
-
Tirofiban